Variant report
Variant | nsv969955 |
---|---|
Chromosome Location | chr5:44357198-44360877 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:44356260..44358499-chr5:45223439..45226183,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11307970 | chr5:44357221-44357222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550299896 | chr5:44357222-44357223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs397997626 | chr5:44357230-44357231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs116672054 | chr5:44357250-44357251 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs111348294 | chr5:44357251-44357252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12656819 | chr5:44357291-44357292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs57614410 | chr5:44357363-44357364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369624444 | chr5:44357370-44357371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188429263 | chr5:44357388-44357389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552762900 | chr5:44357469-44357470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572672934 | chr5:44357493-44357494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538749603 | chr5:44357542-44357543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558968192 | chr5:44357543-44357544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201792782 | chr5:44357606-44357607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191402541 | chr5:44357612-44357613 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544642020 | chr5:44357628-44357629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185079569 | chr5:44357668-44357669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368642449 | chr5:44357688-44357689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530907031 | chr5:44357697-44357698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575245158 | chr5:44357698-44357699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549583165 | chr5:44357704-44357705 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540895906 | chr5:44357725-44357726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200246807 | chr5:44357777-44357778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532708548 | chr5:44357791-44357792 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79970442 | chr5:44357807-44357808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565034260 | chr5:44357909-44357910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs151052514 | chr5:44357989-44357990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550582962 | chr5:44358042-44358043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11951940 | chr5:44358055-44358056 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs141046313 | chr5:44358088-44358089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546441430 | chr5:44358098-44358099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566337874 | chr5:44358197-44358198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs538866674 | chr5:44358204-44358205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372661892 | chr5:44358225-44358226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143749582 | chr5:44358229-44358230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs78203785 | chr5:44358251-44358252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs138977087 | chr5:44358309-44358310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189394001 | chr5:44358344-44358345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs142232418 | chr5:44358376-44358377 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547341892 | chr5:44358379-44358380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560106239 | chr5:44358391-44358392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371689319 | chr5:44358437-44358438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144621631 | chr5:44358475-44358476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138539089 | chr5:44358494-44358495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546426625 | chr5:44358530-44358531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562921732 | chr5:44358532-44358533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182014712 | chr5:44358631-44358632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543941811 | chr5:44358656-44358657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552055909 | chr5:44358682-44358683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560553520 | chr5:44358733-44358734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Lung cancer | 21569311 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:44355800-44359400 | Enhancers | Fetal Stomach | stomach |
2 | chr5:44356000-44362800 | Enhancers | Fetal Lung | lung |
3 | chr5:44356400-44357400 | Enhancers | Colon Smooth Muscle | Colon |
4 | chr5:44356400-44361400 | Weak transcription | Ovary | ovary |
5 | chr5:44356800-44361600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr5:44357400-44360400 | Weak transcription | Colon Smooth Muscle | Colon |
7 | chr5:44359400-44359800 | Weak transcription | Fetal Stomach | stomach |
8 | chr5:44359800-44360000 | Enhancers | Fetal Stomach | stomach |
9 | chr5:44360000-44361200 | Weak transcription | Fetal Stomach | stomach |
10 | chr5:44360400-44360800 | Enhancers | Colon Smooth Muscle | Colon |
11 | chr5:44360600-44362200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr5:44360800-44362000 | Enhancers | Stomach Smooth Muscle | stomach |
13 | chr5:44360800-44378000 | Weak transcription | Colon Smooth Muscle | Colon |